Ovoca Bio | OVG - Betriebsaufwand

Aktienkurs
8.25
Täglich Wechseln
0.25 3.13%
Monatlich
-2.94%
Jährlich
120.00%
Q2 Prognose
7.04




Betriebsaufwand Veränderung Datum
Akebia Therapeutics USD 63.08M 8.26M 2025-12
Alaunos Therapeutics USD 1.19M 148K 2025-09
ALKERMES USD 326.44M 1.41B 2025-12
Avita Medical AUD 28.02M 1.55M 2025-12
Dianthus Therapeutics USD 69.82M 29.14M 2025-12
Great Western Mining Corporation EUR 486.58K 43.28K 2025-06
Ionis Pharmaceuticals USD 418M 101.1M 2025-12
IQVIA Holdings USD 1.69B 4.47B 2025-12
Malin Corporation EUR 1.1M 400K 2024-12
Moderna USD 1.54B 259M 2025-12
Organon & Co USD 906M 362M 2025-09
Ovoca Bio EUR 1.16M 4.48M 2025-06
Revvity USD 626.22M 25.62M 2025-12
Tectonic Therapeutic USD 21.52M 374K 2025-12
Viatris USD 3.86B 335.7M 2025-12
Xeris Pharmaceuticals USD 69.03M 1.38M 2025-12